Design, synthesis, and pharmacological evaluation of monocyclic pyrimidinones as novel inhibitors of PDE5
about
In silico design of novel hERG-neutral sildenafil-like PDE5 inhibitors.Investigation of PDE5/PDE6 and PDE5/PDE11 selective potent tadalafil-like PDE5 inhibitors using combination of molecular modeling approaches, molecular fingerprint-based virtual screening protocols and structure-based pharmacophore development.Application of ITC-Based Characterization of Thermodynamic and Kinetic Association of Ligands With Proteins in Drug Design
P2860
Design, synthesis, and pharmacological evaluation of monocyclic pyrimidinones as novel inhibitors of PDE5
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Design, synthesis, and pharmac ...... es as novel inhibitors of PDE5
@ast
Design, synthesis, and pharmac ...... es as novel inhibitors of PDE5
@en
Design, synthesis, and pharmac ...... es as novel inhibitors of PDE5
@nl
type
label
Design, synthesis, and pharmac ...... es as novel inhibitors of PDE5
@ast
Design, synthesis, and pharmac ...... es as novel inhibitors of PDE5
@en
Design, synthesis, and pharmac ...... es as novel inhibitors of PDE5
@nl
prefLabel
Design, synthesis, and pharmac ...... es as novel inhibitors of PDE5
@ast
Design, synthesis, and pharmac ...... es as novel inhibitors of PDE5
@en
Design, synthesis, and pharmac ...... es as novel inhibitors of PDE5
@nl
P2093
P356
P1476
Design, synthesis, and pharmac ...... es as novel inhibitors of PDE5
@en
P2093
Guanghui Tian
Huaiyu Yang
Hualiang Jiang
Jianfeng Li
Jingshan Shen
Nicholas Kenneth Terrett
P304
10540-10550
P356
10.1021/JM301159Y
P407
P577
2012-11-19T00:00:00Z